338. Patients Living with HIV Infection Are Less Likely to Receive the Correct Intensity of Statin Therapy for Cardiovascular Disease Risk Reduction

BACKGROUND: Patients living with HIV (PLWH) at risk for atherosclerotic cardiovascular disease (ASCVD) should receive risk reduction interventions recommended in current guidelines. This includes routine ASCVD risk assessments and when eligible, statins selected and dosed to achieve appropriate low-...

Descripción completa

Detalles Bibliográficos
Autores principales: Schafer, Jason J, Patel, Roshni, Hastain, Nicholas V, Miano, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810015/
http://dx.doi.org/10.1093/ofid/ofz360.411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810015/
http://dx.doi.org/10.1093/ofid/ofz360.411

Ejemplares similares